Molecular Basis for Impaired Muscle Differentiation in Myotonic Dystrophy

REFERENCES

• Amack, J. D., A. P. Paguio, and M. S. Mahadevan. 1999. Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model. Hum. Mol. Genet. 8:1975–1984.
   PubMed Web of Science ®Google Scholar
• Antic, D., and J. D. Keene. 1997. Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am. J. Hum. Genet. 61:273–278.
   PubMed Web of Science ®Google Scholar
• Antic, D., N. Lu, and J. D. Keene. 1999. ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neuritis in human teratocarcinoma cells. Genes Dev. 13:449–461.
   PubMedGoogle Scholar
• Bhagwati, S., S. A. Shafiq, and W. Xu. 1999. (CTG)n repeats markedly inhibit differentiation of the C2C12 line: implications for congenital myotonic dystrophy. Biochim. Biophys. Acta 1453:221–229.
   PubMedGoogle Scholar
• Campos, A. R., D. Grossman, and K. White. 1985. Mutant alleles at the locus elav in Drosophila melanogaster lead to nervous system defects. A developmental-genetic analysis. J. Neurogenet. 2:197–218.
   PubMed Web of Science ®Google Scholar
• Caskey, C. T., M. S. Swanson, and L. T. Timchenko. 1996. Myotonic dystrophy: discussion of molecular mechanism. Cold Spring Harbor Symp. Quant. Biol. 61:607–614.
   PubMedGoogle Scholar
• Chen, L., P. Scully, J. Y. Shew, J. V. Wang, and W. H. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modulated during cell cycle and cellular differentiation. Cell 58:1193–1198.
   PubMed Web of Science ®Google Scholar
• Davis, B. M., M. E. McCurrach, K. L. Taneja, R. H. Singer, and D. E. Housman. 1997. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonin protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. USA 94:7388–7393.
   PubMed Web of Science ®Google Scholar
• Dyson, N.. 1998. The regulation of E2F by Rb family proteins. Genes Dev. 12:2245–2262.
   PubMed Web of Science ®Google Scholar
• Good, P. J., Q. Chen, S. J. Warner, and D. C. Herring. 2000. A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. J. Biol. Chem. 275:28583–28592.
   PubMed Web of Science ®Google Scholar
• Jain, R. G., L. G. Andrews, K. M. McGowan, P. H. Pekala, and J .D. Keene. 1997. Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3–L1 adipocytes. Mol. Cell. Biol. 17:954–962.
   PubMedGoogle Scholar
• Jansen, G., P. J. Groenen, D. Bachner, P. H. Jap, M. Coerwinkel, F. Oerlemans, W. van den Broek, B. Gohlsch, D. Pette, J. J. Plomp, P. C. Molenaar, M. G. Nederhoff, C. J. van Echteld, M. Dekker, A. Berns, H. Hameister, and B. Wieringa. 1996. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat. Genet. 13:316–324.
   PubMedGoogle Scholar
• Joseph, B., M. Orlian, and H. Furneaux. 1998. p21 (waf1) mRNA contains a conserved elements in its 3′-untranslated region that is bound by the Elav-like mRNA-stabilizing proteins. J. Biol. Chem. 273:20511–20516.
   PubMedGoogle Scholar
• Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (Rb) and Rb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331–342.
   PubMed Web of Science ®Google Scholar
• Khajavi, M., A. M. Tari, N. B. Patel, K. Tsuji, D. R. Siwak, M. L. Meistrich, N. H. A. Terry, and T. Ashizawa. 2001. “Mitotic drive” of expanded CCTG repeats in myotonic dystrophy type 1 (DM1). Hum. Mol. Genet. 10:855–863.
   PubMedGoogle Scholar
• Kiess, M., R. M. Gill, and P. A. Hamel. 1995. Expression and activity of retinoblastoma protein (pRb)-family proteins, p107 and p130, during L6 myoblast differentiation. Cell Growth Differ. 6:1287–1298.
   PubMedGoogle Scholar
• Klesert, T. R., D. H. Cho, J. I. Clark, J. Maylie, J. Adelman, L. Snider, E. C. Yuen, P. Soriano, and S. J. Tapscott. 2000. Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy. Nat. Genet. 25:105–109.
   PubMedGoogle Scholar
• Levine, T. D., F. Gao, P. H. King, L. G. Andrews, and J. D. Keene. 1993. Hel-N1: an autoimmune RNA-binding protein with specificity for 3′ uridylate-rich untranslated regions of growth factors mRNAs. Mol. Cell. Biol. 13:3494–3504.
   PubMed Web of Science ®Google Scholar
• Lu, X., N. A. Timchenko, and L. T. Timchenko. 1999. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum. Mol. Genet. 8:53–60.
   PubMedGoogle Scholar
• Mankodi, A., E. Logigian, L. Callahan, C. McClain, R. White, D. Henderson, M. Krym, and C. A. Thornton. 2000. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289:1769–1773.
   PubMed Web of Science ®Google Scholar
• Miller, J. W., C. R. Urbinati, P. Teng-Umnuay, M. G. Stenberg, B. J. Byrne, C. A. Thornton, and M. S. Swanson. 2000. Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy. EMBO J. 19:4439–4448.
   PubMed Web of Science ®Google Scholar
• Milne, C. A., and J. Hodgkin. 1999. ETR-1, a homologue of a protein linked to myotonic dystrophy, is essential for muscle development in Caenorhabditis elegans. Curr. Biol. 9:1243–1246.
   PubMedGoogle Scholar
• Nakanishi, M., R. S. Robetorye, O. M. Pereira-Smith, and J. R. Smith. 1997. The C-terminal region of p21 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition. J. Biol. Chem. 270:17060–17063.
   Google Scholar
• Novitch, B. G., G. J. Mulligan, T. Jacks, and A. B. Lassar. 1996. Skeletal muscle cells lacking the retinoblastome protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135:441–456.
   PubMed Web of Science ®Google Scholar
• Phillips, A. V., L. T. Timchenko, and T. A. Cooper. 1998. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280:737–741.
   PubMedGoogle Scholar
• Puri, P. L., L. Cimino, M. Fulco, C. Zimmerman, N. B. La Tanguen, A. Giordano, A. Graesmann, and M. Levrero. 1998. Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation. Cancer Res. 58:1325–1331.
   PubMed Web of Science ®Google Scholar
• Reddy, S., D. B. Smith, M. M. Rich, J. M. Leferovich, P. Reilly, K. Tran, H. Rayburn, R. Bronson, D. Cros, R. J. Balice-Gordon, and D. Housman. 1996. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat. Genet 13:325–335.
   PubMedGoogle Scholar
• Reynaud, E. G., K. Pelpel, M. Cuillier, M. P. Leibovitch, and S. A. Leibovitch. 1999. p57 stabilizes the MyoD protein by inhibiting cyclin E-cdk2 kinase activity in growing myoblasts. Mol. Cell. Biol. 19:7621–7629.
   PubMed Web of Science ®Google Scholar
• Roberts, R., N. A. Timchenko, J. W. Miller, S. Reddy, C. T. Caskey, M. S. Swanson, and L. T. Timchenko. 1997. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc. Natl. Acad. Sci. USA 94:13221–13226.
   PubMed Web of Science ®Google Scholar
• Sabourin, L. A., K. Tamai, M. A. Narang, and R. G. Korneluk. 1997. Overexpression of 3′-untranslated region of the myotonic dystrophy kinase cDNA inhibits myoblasts differentiation in vitro. J. Biol. Chem. 272:29626–29635.
   PubMedGoogle Scholar
• Sarkar, P. S., B. Appukuttan, J. Han, Y. Ito, C. Ai, W. Tsai, Y. Chai, J. T. Stout, and S. Reddy. 2000. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nat. Genet. 25:110–114.
   PubMedGoogle Scholar
• Taneja, K. L., M. McCurrach, M. Schalling, D. Housman, and R. H. Singer. 1995. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell. Biol. 128:995–1002.
   PubMed Web of Science ®Google Scholar
• Timchenko, L. T.. 1999. Myotonic dystrophy: the role of RNA CUG triplet repeats. Am. J. Hum. Genet. 64:360–364.
   PubMedGoogle Scholar
• Timchenko, L. T., J. W. Miller, N. A. Timchenko, D. R. DeVore, K. V. Datar, L. Lin, R. Roberts, C. T. Caskey, and M. S. Swanson. 1996. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 24:4407–4414.
   PubMed Web of Science ®Google Scholar
• Timchenko, L. T., N. A. Timchenko, C. T. Caskey, and R. Roberts. 1996. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy. Hum. Mol. Genet. 5:115–121.
   PubMedGoogle Scholar
• Timchenko, N. A., Z.-J. Cai, A. L. Welm, S. Reddy, T. Ashizawa, and L. T. Timchenko. 2001. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol. Chem. 276:7820–7826.
   PubMed Web of Science ®Google Scholar
• Timchenko, N. A., A. L. Welm, X. Lu, and L. T. Timchenko. 1999. CUG repeat binding protein (CUGBP1) interacts with the 5′ region of C/EBPβ mRNA and regulates translation of C/EBPβ isoforms. Nucleic Acids Res. 27:4517–4525.
   PubMed Web of Science ®Google Scholar
• Timchenko, N. A., M. Wilde, M. Nakanishi, J. R. Smith, and G. J. Darlington. 1996. CCAAT/Enhancer binding protein α (C/EBPα) inhibits cell proliferation through p21 protein. Genes Dev. 10:804–815.
   PubMed Web of Science ®Google Scholar
• Wang, J., E. Pegoraro, E. Menegazzo, M. Gennarelli, R. C. Hoop, C. Angelini, and E. P. Hoffman. 1995. Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum. Mol. Genet. 4:599–606.
   PubMedGoogle Scholar
• Wang, W., H. Furneaux, H. Cheng, M. C. Caldwell, D. Hutter, L. Yusen, N. Holbrook, and M. Gorospe. 2000. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell. Biol. 20:760–769.
   PubMed Web of Science ®Google Scholar
• Welm, A. L., S. Mackey, L. T. Timchenko, G. J. Darlington, and N. A. Timchenko. 2000. Translational induction of Liver-enriched transcriptional inhibitory protein during acute phase response leads to repression of CCAAT/Enhancer binding protein α mRNA. J. Biol. Chem. 275:27406–27413.
   PubMed Web of Science ®Google Scholar
• Zhang, P., C. Wong, D. Liu, M. Finegold, W. J. Harper, and S. J. Elledge. 1999. p21 and p57 control muscle differentiation at the myogenin step. Genes Dev. 13:213–224.
   PubMed Web of Science ®Google Scholar